The purpose of Volume 2 is to provide a full set of reference data showing performance over the period of the previous National Health Plan 2001–2010, to provide a baseline against which performance over the next ten years can be measured, and to highlight in greater detail some of the contex...t against which the policies and strategies described in Volume 1 can be understood.
This Part A of Volume 2 provides data and context from a whole-of-country perspective. The data will be useful for provinces and national-level program staff within the National Department of Health to establish benchmarks and targets in the Five-year Strategic Implementation Plans to be developed to support implementation of this Plan. Additionally, this Volume will serve as a reference manual for all health sector stakeholders.
Original file: 77 MB
more
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resistance and lead to loss of confidence in health prof...essionals, manufacturers and distributors and in health systems. In an effort to protect people’s health, the WHO Regional Director for Africa, Dr Matshidiso Moeti, has proposed a strategy aimed at strengthening National Medicine Regulatory Authorities (NMRAs) in order to ensure that only safe, good quality and effective medical products are available.
more
This report provides an overview of the Key findings of the Rwanda 2014-2015 Demographic and Health Survey (RDHS). The 2014-15 Rwanda Demographic and Health Survey (RDHS) was designed to provide data for monitoring the population and health situation in Rwanda. The 2014-15 RDHS is the fifth Demogra...phic and Health Survey
conducted in Rwanda since 1992. The objective of the survey was to provide reliable estimates of fertility levels, marriage, sexual activity, fertility preferences, family planning methods, breastfeeding practices, nutrition, childhood and maternal mortality, maternal and child health, early childhood development, malaria, domestic violence, and HIV/AIDS and other sexually transmitted infections (STIs) that can be used by program managers and policymakers to evaluate and improve existing programs.
more
Epidemiologisches Bulletin; 1. Dezember 2014 / Nr. 48
UNICEF’s Global HIV Response 2018 – 2021
Accessed: 02.11.2019
Clinical Guidance across the continuum of care
Chapter 8_ARV Guidelines
Les femmes aborigènes ouvrent la voie
Mars 2014
Recommended actions at international and national levels
Rapport d’étape au 30 novembre 2011
DHS Analytical Studies No. 40
Issues in Educational Research, 26(1), 2016
Neonatal mortality is a major challenge in reducing child mortality rates in Nepal. Despite efforts by the Government of Nepal, data from the last three demographic and health surveys show a rise in the contribution of neonatal deaths to infant and child mortality. The Government of Nepal has implem...ented community-based programs that were piloted and then scaled up based on lessons learned. These programs include, but are not limited to ensuring safe motherhood, birth preparedness package, community-based newborn care package, and integrated management of childhood illnesses. Despite the implementation of such programs on a larger scale, their effective coverage is yet to be achieved. Health system challenges included an inadequate policy environment, funding gaps, inadequate procurement, and insufficient supplies of commodities, while human resource management has been found to be impeding service delivery. Such bottlenecks at policy, institutional and service delivery level need to be addressed incorporating health information in decision-making as well as working in partnership with communities to facilitate the utilization of available services.
more
Other disorders
Chapter H.5
El uso de los antimicrobianos en seres humanos es imprescindible para combatir a los microorganismos causantes de distintas enfermedades, no obstante, el uso y abuso de estos productos farmacéuticos ha propiciado un aumento en la resistencia, desarrollo y propagación de microorganismos multirresis...tentes. Consecuentemente, esto ha ocasionado una amenaza para la salud pública y un impacto en las Infecciones Asociadas a la Atención en Salud (IAAS). Las IAAS producen un aumento en la mortalidad, morbilidad, estancia hospitalaria, discapacidades en los pacientes, gastos en los servicios de salud, entre otros. Las IAAS son causadas por microorganismos tales como bacterias, virus, hongos, parásitos o priones y pueden afectar tanto a los pacientes como al personal sanitario du- rante la atención de la salud
more